Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Treace Medical Concepts (TMCI) FCF Margin (2020 - 2026)

Treace Medical Concepts filings provide 6 years of FCF Margin readings, the most recent being 16.67% for Q4 2025.

  • On a quarterly basis, FCF Margin fell 608.0% to 16.67% in Q4 2025 year-over-year; TTM through Dec 2025 was 13.86%, a 943.0% increase, with the full-year FY2025 number at 13.86%, up 943.0% from a year prior.
  • FCF Margin hit 16.67% in Q4 2025 for Treace Medical Concepts, up from 23.7% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 1.25% in Q1 2025 to a low of 52.48% in Q2 2022.
  • Median FCF Margin over the past 5 years was 22.76% (2024), compared with a mean of 24.45%.
  • Biggest five-year swings in FCF Margin: tumbled -3095bps in 2022 and later soared 2306bps in 2025.
  • Treace Medical Concepts' FCF Margin stood at 14.03% in 2021, then decreased by -10bps to 15.45% in 2022, then skyrocketed by 82bps to 2.76% in 2023, then tumbled by -284bps to 10.6% in 2024, then crashed by -57bps to 16.67% in 2025.
  • The last three reported values for FCF Margin were 16.67% (Q4 2025), 23.7% (Q3 2025), and 16.5% (Q2 2025) per Business Quant data.